Floatz logo

Therapeutic Asset Ratings

622 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Etx-19477
Breast Cancer
858 Therapeutics, Inc.P1/2CC (40)
Gdc-4198
Breast Cancer
Genentech, Inc.P1/2CC (40)
gm103
Breast Cancer
GeneMedicine Co., Ltd.P1/2CC (40)
her2 fpbmc
Breast Cancer
University of VirginiaP1/2CC (40)
Icasp9M28Z T Cell Infusions
Breast Cancer
Memorial Sloan Kettering Cancer CenterP1/2CC (40)
INX315
Breast Cancer
Incyclix BioP1/2CC (40)
LEVAMLODIPINE
Breast Cancer
Tanta UniversityP1/2CC (40)
MANNITOL
Breast Cancer
National Taiwan University HospitalP1/2CC (40)
mdx2001
Breast Cancer
ModeX Therapeutics, An OPKO Health CompanyP1/2CC (40)
Micardis®
Breast Cancer
Tanta UniversityP1/2CC (40)
Mirdametinib
Breast Cancer
Memorial Sloan Kettering Cancer CenterP1/2CC (40)
mt-4561
Breast Cancer
Tanabe Pharma America, Inc.P1/2CC (40)
NEOMYCIN
Breast Cancer
Jewish General HospitalP1/2CC (40)
ngm707
Breast Cancer
NGM Biopharmaceuticals, IncP1/2CC (40)
Palacaparib
Breast Cancer
AstraZenecaP1/2CC (40)
Pirfenidone
Breast Cancer
Harbin Medical UniversityP1/2CC (40)
POLO-LIKE KINASE 1 INHIBITOR NMS-1286937
Breast Cancer
Antonio Giordano, MDP1/2CC (40)
Pumitamig
Breast Cancer
Bristol-Myers SquibbP1/2CC (40)
Puxitatug Samrotecan
Breast Cancer
AstraZenecaP1/2CC (40)
Rezatapopt
Breast Cancer
PMV Pharmaceuticals, IncP1/2CC (40)
Shr-A1811 For
Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.P1/2CC (40)
SL-28
Breast Cancer
Second Life TherapeuticsP1/2CC (40)
Solnerstotug
Breast Cancer
Sensei Biotherapeutics, Inc.P1/2CC (40)
st101
Breast Cancer
Sapience TherapeuticsP1/2CC (40)
syh2051
Breast Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.P1/2CC (40)
Showing 401 to 425 of 622 assets
PreviousPage 17 of 25Next